Published in Neurology on April 11, 2006
Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol (2010) 2.73
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol (2009) 2.67
REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci (2010) 2.46
A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol (2008) 2.44
100 years of Lewy pathology. Nat Rev Neurol (2012) 2.15
Medical records documentation of constipation preceding Parkinson disease: A case-control study. Neurology (2009) 1.64
Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol (2008) 1.46
Genetic neuropathology of Parkinson's disease. Int J Clin Exp Pathol (2008) 1.11
Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies? Neurobiol Aging (2009) 1.04
Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. Arch Neurol (2009) 1.03
Long-term health of dopaminergic neuron transplants in Parkinson's disease patients. Cell Rep (2014) 1.02
Multi-organ autonomic dysfunction in Parkinson disease. Parkinsonism Relat Disord (2010) 1.01
TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies. Acta Neuropathol (2013) 0.95
The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience (2007) 0.91
α-Synuclein and mitochondrial dysfunction in Parkinson's disease. Mol Neurobiol (2013) 0.91
Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers. J Neuropathol Exp Neurol (2014) 0.89
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease. J Neural Transm (Vienna) (2010) 0.87
Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone. Neuroscience (2011) 0.84
Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy? Acta Neuropathol (2008) 0.83
Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies. J Neurochem (2011) 0.83
Nerve cells immunoreactive for p62 in select hypothalamic and brainstem nuclei of controls and Parkinson's disease cases. J Neural Transm (Vienna) (2010) 0.82
Spinal cord pathology in alpha-synuclein transgenic mice. Parkinsons Dis (2010) 0.79
Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease. FEBS Lett (2015) 0.78
What ARE Parkinson disease? Non-motor features transform conception of the shaking palsy. Neurobiol Dis (2012) 0.77
Higher Prevalence of TDP-43 Proteinopathy in Cognitively Normal Asians: A Clinicopathological Study on a Multiethnic Sample. Brain Pathol (2015) 0.76
Seniors with Parkinson's disease: initial medical treatment. J Clin Neurol (2010) 0.75
Comparison of alpha-synuclein immunoreactivity in the spinal cord between the adult and aged beagle dog. Lab Anim Res (2012) 0.75
Neuropathology of Parkinson disease. Parkinsonism Relat Disord (2017) 0.75
Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration. Surg Neurol Int (2017) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Classification of primary progressive aphasia and its variants. Neurology (2011) 11.82
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology (1999) 9.86
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet (2000) 6.12
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol (1997) 6.02
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science (2001) 6.00
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology (2004) 5.86
Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology (2005) 5.02
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology (2000) 4.89
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology (2004) 4.74
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology (2002) 4.50
Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology (2008) 4.31
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28
Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol (1996) 4.10
Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology (2000) 3.84
Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology (2010) 3.83
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain (2007) 3.82
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology (2006) 3.60
A neuronal antigen in the brains of Alzheimer patients. Science (1986) 3.49
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology (2004) 3.41
Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology (2011) 3.30
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology (2007) 3.24
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain (2008) 3.05
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology (2012) 3.01
Superficial siderosis. Neurology (2006) 2.98
Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology (2007) 2.93
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology (1999) 2.81
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord (1994) 2.77
Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain (2000) 2.76
Aversive properties of the negative stimulus in a successive discrimination. J Exp Anal Behav (1969) 2.75
Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol (1993) 2.75
The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp Neurol (1999) 2.73
MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology (2008) 2.69
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. Neurology (2012) 2.68
Cognitive impairment after ECT in patients with Parkinson's disease and psychiatric illness. Am J Psychiatry (1992) 2.68
Memory and MRI-based hippocampal volumes in aging and AD. Neurology (2000) 2.65
Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol (1997) 2.60
REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology (2010) 2.50
Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol (1993) 2.46
Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology (2008) 2.45
1H MR spectroscopy in common dementias. Neurology (2004) 2.39
APOE modifies the association between Aβ load and cognition in cognitively normal older adults. Neurology (2011) 2.35
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology (2000) 2.31
Remote cerebellar hemorrhage after supratentorial surgery. Neurosurgery (2001) 2.30
Frontotemporal brain sagging syndrome: an SIH-like presentation mimicking FTD. Neurology (2011) 2.27
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology (2000) 2.26
Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol (1994) 2.25
Cockayne syndrome and xeroderma pigmentosum. Neurology (2000) 2.24
Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology (2007) 2.22
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord (2000) 2.20
Hemangiopericytoma of the central nervous system: a review of 94 cases. Hum Pathol (1991) 2.12
Selective peripheral denervation for torticollis: preliminary results. Mayo Clin Proc (1991) 2.12
DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology (2004) 2.12
Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology (2003) 2.10
Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med (1985) 2.09
Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology (2009) 2.09
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology (2008) 2.01
Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci (1997) 2.00
Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord (2001) 2.00
Pathology and biology of the Lewy body. J Neuropathol Exp Neurol (1993) 1.99
Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology (2003) 1.97
Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc Natl Acad Sci U S A (1987) 1.96
Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol (1993) 1.93
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology (2010) 1.93
Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology (2001) 1.92
Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol (1993) 1.91
Diffusion tensor imaging and cognitive function in older adults with no dementia. Neurology (2011) 1.89
Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol (1991) 1.89